Two stocks in Healthcare
Amgen vs HCA Healthcare: profit, growth, debt and price compared
Amgen is stronger on 4 of 6 figures: profit margin, sales growth, dividend and price trend. HCA Healthcare is stronger on 2: price for its expected profit and analysts' view.
Save both stocks to your watchlist and revisit their latest fundamentals.
| AmgenAMGN | HCA HealthcareHCA | |
|---|---|---|
| Net margin | Stronger: 24.1% | 8.6% |
| Revenue growth, past year | Stronger: +8.45% | +3.59% |
| Debt to equity | 376.3% | — |
| Forward P/E | 17.7× | Stronger: 15.2× |
| Dividend yield | Stronger: 2.27% | 0.64% |
| Analysts | Hold · 29 | Stronger: Buy · 22 |
| From its 200-day average | Stronger: +14.8% | +8.5% |
Share price over the past year
- Amgen+29.0%
- HCA Healthcare−0.4%
18 Nov 202518 Nov 2026
Amgen or HCA Healthcare: which is stronger?
- AMGN
Which is more profitable?
Amgen keeps more of each sale as profit: 24.1% against 8.6%.
- AMGN
Which is growing its sales faster?
Amgen is growing its sales faster: +8.45% over the past year, against +3.59%.
- HCA
Which costs less for the profit it is expected to make?
HCA Healthcare costs less for the profit it is expected to make: 15.2× its forward earnings, against 17.7×.
- AMGN
Which pays more in dividends?
Amgen pays more back in dividends for what a share costs: 2.27% a year, against 0.64%.
- HCA
Which do analysts rate higher?
Analysts are warmer on HCA Healthcare: Buy, against Hold for Amgen.
- AMGN
Which is in the stronger price trend?
Amgen's price is in the stronger trend: 14.8% above its 200-day average, against 8.5% above.
What each company does
AMGNAmgen
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
Reports results on 2 February 2027
HCAHCA Healthcare
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
Reports results on 26 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.